MARKET

TEVA

TEVA

Teva Pharm Ind
NYSE

Real-time Quotes | Nasdaq Last Sale

10.61
+0.19
+1.82%
Opening 14:44 05/14 EDT
OPEN
10.50
PREV CLOSE
10.42
HIGH
10.68
LOW
10.48
VOLUME
3.36M
TURNOVER
--
52 WEEK HIGH
13.30
52 WEEK LOW
8.44
MARKET CAP
11.64B
P/E (TTM)
-2.9194
1D
5D
1M
3M
1Y
5Y
Travere tumbles as Teva bags FDA approval for generic of Thiola
Travere Therapeutics ([[TVTX]] -9.3%) has dropped sharply in morning hours after the FDA website indicated the approval for Abbreviated New Drug Application ((ANDA)) submitted by Teva Pharmaceuticals ([[TEVA]] +2.0%) for Tiopronin Tablets,
Seekingalpha · 2h ago
Eversept Partners, LLC Buys ARK Genomic Revolution ETF, Acceleron Pharma Inc, Community Health ...
GuruFocus News · 22h ago
Methotrexate Market 2021 - Industry, Share, Size, Dynamics, Manufacturer, Standing, Viewpoint and Prospects: 2027
Market Stats News · 2d ago
Parkinson's Disease Drugs Market Detailed Analysis of Current Industry Figures with Forecasts Growth By 2027
May 12, 2021 (AmericaNewsHour) -- The latest market report published by Research Nester The global Parkinson's disease drugs market can be segmented on the...
AmericaNewsHour · 2d ago
Topical Use Acne Treatment Market to Witness Astonishing Growth with Key Players, Analysis with Impact of COVID-19, Analysis, Demand, Forecast 2026
May 12, 2021 (The Expresswire) -- Global "Topical Use Acne Treatment Market"(2021-2026) provides an all-inclusive assessment of the market and offers a...
The Express Wire · 2d ago
Opioid Use Disorder Market Size 2021 | Is Projected to grow USD 4.81 billion in 2028 at a CAGR of 8.7%
Pune, India, May 12, 2021 (GLOBE NEWSWIRE via COMTEX) -- Pune, India, May 12, 2021 (GLOBE NEWSWIRE) -- Opioid Use Disorder Market Size| 2021 Covid-19 Impact...
GlobeNewswire · 2d ago
Transdermal Skin Patch Market Size 2021, Growth Factors, Major Key Players, Regional Analysis with Impact of Covid-19, Emerging Trends, Production Capacity | Current Expansion Plans and Forecast to 2027
May 12, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The Global “Transdermal Skin Patch Market”...
The Express Wire · 2d ago
Dilated Cardiomyopathy Therapeutic Market Size 2021-2027 | Production Capacity Estimates, Industry On Going Trends, Development History, Regional Overview, Share Estimation, Revenue, and Business Prospect
May 12, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The global “Dilated Cardiomyopathy...
The Express Wire · 2d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TEVA. Analyze the recent business situations of Teva Pharm Ind through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 24 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TEVA stock price target is 12.20 with a high estimate of 17.00 and a low estimate of 9.00.
EPS
Institutional Holdings
Institutions: 710
Institutional Holdings: 608.11M
% Owned: 55.45%
Shares Outstanding: 1.10B
TypeInstitutionsShares
Increased
125
25.33M
New
62
7.43M
Decreased
153
25.53M
Sold Out
52
3.23M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.54%
Pharmaceuticals & Medical Research
+1.16%
Key Executives
Chairman/Independent Director
Sol Barer
President/Chief Executive Officer/Director
Kaare Schultz
Chief Financial Officer/Executive Vice President/Director
Eli Kalif
Chief Financial Officer/Executive Vice President
Eliyahu Kalif
Chief Human Resource Officer/Executive Vice President
Mark Sabag
Executive Vice President
Richard Daniell
Executive Vice President
Sven Dethlefs
Executive Vice President
Eric Drape
Executive Vice President
Hafrun Fridriksdottir
Executive Vice President
Brendan O'Grady
Executive Vice President
David Stark
Chief Accounting Officer
Andrew Weil
Independent Director
Rosemary Crane
Independent Director
Amir Elstein
Independent Director
Jean-Michel Halfon
Independent Director
Abbas Hussain
Independent Director
Gerald Lieberman
Independent Director
Roberto Mignone
Independent Director
Perry Nisen
Independent Director
Nechemia Peres
Independent Director
Ronit Satchi-Fainaro
Independent Director
Janet Vergis
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 0.072
11/27/2017
08/04/2017
Dividend USD 0.072
08/25/2017
05/16/2017
Dividend USD 0.289
06/01/2017
03/16/2017
Dividend USD 0.289
02/28/2017
11/17/2016
Dividend USD 0.289
12/01/2016
08/08/2016
Dividend USD 0.289
08/18/2016
05/11/2016
Dividend USD 0.289
05/20/2016
02/16/2016
Dividend USD 0.289
02/25/2016
11/02/2015
Dividend USD 0.289
11/13/2015
07/31/2015
Dividend USD 0.289
08/18/2015
05/05/2015
Dividend USD 0.289
05/15/2015
02/20/2015
Dividend USD 0.294
02/17/2015
11/18/2014
Dividend USD 0.27
11/13/2014
08/25/2014
Dividend USD 0.291
08/19/2014
05/20/2014
Dividend USD 0.298
05/16/2014
03/05/2014
Dividend USD 0.293
02/20/2014
11/21/2013
Dividend USD 0.278
11/18/2013
08/21/2013
Dividend USD 0.274
08/16/2013
  • All
  • Financials
  • Insiders
More
About TEVA
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Webull offers kinds of Teva Pharmaceutical Industries Ltd (ADR) stock information, including NYSE:TEVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TEVA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TEVA stock methods without spending real money on the virtual paper trading platform.